Barclays
MBIO icon

Barclays’s Mustang Bio MBIO Stock Holding History

Barclays’s Portfolio MBIO Stock Details MBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-83
Closed -$8.56K – 5302
2023
Q3 		$8.56K Hold
83
– – ﹤0.01% 4326
2023
Q2 		$25.7K Buy
+83
New +$20.8K ﹤0.01% 4083
2022
Q4 		– Sell
-86
Closed -$30K – 5334
2022
Q3 		$30K Sell
86
-7
-8% -$3.24K ﹤0.01% 3941
2022
Q2 		$41K Sell
93
-16
-15% -$8.86K ﹤0.01% 4111
2022
Q1 		$83K Sell
109
-102
-48% -$83.8K ﹤0.01% 3867
2021
Q4 		$263K Buy
211
+91
+76% +$147K ﹤0.01% 3466
2021
Q3 		$242K Buy
120
+53
+79% +$114K ﹤0.01% 3524
2021
Q2 		$166K Sell
67
-44
-40% -$108K ﹤0.01% 3633
2021
Q1 		$277K Buy
111
+89
+405% +$265K ﹤0.01% 3548
2020
Q4 		$61K Buy
22
+5
+29% +$12K ﹤0.01% 4330
2020
Q3 		$41K Sell
17
-4
-19% -$9.86K ﹤0.01% 4688
2020
Q2 		$50K Buy
21
+9
+75% +$21K ﹤0.01% 4935
2020
Q1 		$25K Sell
12
-25
-68% -$64.1K ﹤0.01% 5567
2019
Q4 		$114K Buy
37
+19
+106% +$43.5K ﹤0.01% 5405
2019
Q3 		$45K Sell
18
-6
-25% -$16.4K ﹤0.01% 5959
2019
Q2 		$66K Buy
24
+18
+300% +$51.4K ﹤0.01% 5952
2019
Q1 		$16K Buy
+6
New +$17K ﹤0.01% 6428
2018
Q4 		– Sell
-8
Closed -$36K – 7153
2018
Q3 		$36K Buy
8
+6
+300% +$30K ﹤0.01% 6247
2018
Q2 		$8K Sell
2
-8
-80% -$50.5K ﹤0.01% 6614
2018
Q1 		$81K Buy
+10
New +$85.2K ﹤0.01% 5536

Other funds holding MBIO

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KOC
Koss-Olinger Consulting Gainesville, Florida $1.19B AUM 15.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Barclays's MBIO Position: Q4 2023 in Review

Barclays sold out of Mustang Bio (MBIO) in Q4 2023, closing a stake of 83 shares — an estimated $8.56K sold.

Barclays first reported a position in MBIO in Q1 2018 and held it in 20 quarters. The position peaked at $277K in Q1 2021. 25 funds tracked by Wall St. Rank hold MBIO as of Q4 2023.

  • Barclays reported no remaining Mustang Bio position as of Q4 2023 after selling out during the quarter.
  • Barclays sold 83 Mustang Bio shares in Q4 2023, an estimated $8.56K.
  • Barclays first reported a position in Mustang Bio in Q1 2018 and held it in 20 quarters.
  • Barclays's Mustang Bio position peaked at $277K in Q1 2021.
  • 25 funds tracked by Wall St. Rank held Mustang Bio as of Q4 2023.

Based on Barclays's 13F filing for Q4 2023, filed 15 Feb 2024.